Winning Points Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.52M | Sell |
6,779
-110
| -2% | -$24.4K | 2.04% | 10 |
|
|
2025
Q4 | $1.57M | Buy |
+6,889
| New | +$1.57M | 1.68% | 10 |
|
|
2024
Q3 | $1.1M | Buy |
+7,223
| New | +$1.35M | 1.86% | 11 |
|
|
2024
Q1 | $1.12M | Hold |
7,223
| – | – | 1.72% | 11 |
|
|
2023
Q4 | $1.12M | Hold |
7,223
| – | – | 1.72% | 11 |
|
|
2023
Q3 | $1.1M | Hold |
7,223
| – | – | 1.95% | 9 |
|
|
2023
Q2 | $1.12M | Hold |
7,223
| – | – | 1.72% | 11 |
|
|
2023
Q1 | $1.15M | Hold |
7,223
| – | – | 1.27% | 17 |
|
|
2022
Q4 | $1.17M | Sell |
7,223
-15
| -0.2% | -$2.3K | 1.49% | 17 |
|
|
2022
Q3 | $1.05M | Sell |
7,238
-19
| -0.3% | -$2.73K | 1.28% | 18 |
|
|
2022
Q2 | $1.11M | Hold |
7,257
| – | – | 1.22% | 18 |
|
|
2022
Q1 | $1.18M | Sell |
7,257
-419
| -5% | -$60.9K | 0.91% | 25 |
|
|
2021
Q4 | $558K | Buy |
7,676
+419
| +6% | +$49.5K | 0.41% | 45 |
|
|
2021
Q3 | $783K | Buy |
7,257
+219
| +3% | +$25K | 0.57% | 34 |
|
|
2021
Q2 | $793K | Sell |
7,038
-396
| -5% | -$44.6K | 0.59% | 34 |
|
|
2021
Q1 | $805K | Buy |
7,434
+158
| +2% | +$16.9K | 0.6% | 35 |
|
|
2020
Q4 | $780K | Sell |
7,276
-486
| -6% | -$46.7K | 0.63% | 31 |
|
|
2020
Q3 | $680K | Hold |
7,762
| – | – | 0.58% | 33 |
|
|
2020
Q2 | $762K | Buy |
7,762
+86
| +1% | +$7.57K | 0.73% | 29 |
|
|
2020
Q1 | $585K | Hold |
7,676
| – | – | 0.57% | 35 |
|
|
2019
Q4 | $680K | Hold |
7,676
| – | – | 0.43% | 45 |
|
|
2019
Q3 | $575K | Hold |
7,676
| – | – | 0.41% | 45 |
|
|
2019
Q2 | $558K | Hold |
7,676
| – | – | 0.41% | 45 |
|
|
2019
Q1 | $619K | Hold |
7,676
| – | – | 0.48% | 42 |
|
|
2018
Q4 | $685K | Hold |
7,676
| – | – | 0.59% | 36 |
|
|
2018
Q3 | $726K | Hold |
7,676
| – | – | 0.53% | 41 |
|
|
2018
Q2 | $711K | Hold |
7,676
| – | – | 0.57% | 37 |
|
|
2018
Q1 | $706K | Hold |
7,676
| – | – | 0.58% | 38 |
|
|
2017
Q4 | $742K | Hold |
7,676
| – | – | 0.6% | 36 |
|
|
2017
Q3 | $504K | Hold |
7,676
| – | – | 0.43% | 46 |
|
|
2017
Q2 | $556K | Hold |
7,676
| – | – | 0.54% | 40 |
|
|
2017
Q1 | $500K | Buy |
7,676
+205
| +3% | +$12.9K | 0.49% | 43 |
|
|
2016
Q4 | $468K | Buy |
+7,471
| New | +$456K | 0.51% | 45 |
|
Other funds holding ABBV
VCM
VPM
Winning Points Advisors's ABBV Position: Q1 2026 in Review
Winning Points Advisors reduced its AbbVie (ABBV) stake by 1.6% in Q1 2026, selling an estimated $24.4K and leaving 6,779 shares worth $1.52M. The position accounts for 2.04% of the portfolio, ranked #10.
Winning Points Advisors first reported a position in ABBV in Q4 2016 and has held it in 33 quarters since. The position peaked at $1.57M in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Winning Points Advisors held 6,779 shares of AbbVie worth $1.52M as of Q1 2026.
- Winning Points Advisors sold 110 AbbVie shares in Q1 2026, an estimated $24.4K.
- AbbVie made up 2.04% of Winning Points Advisors's portfolio in Q1 2026, its #10 holding.
- Winning Points Advisors first reported a position in AbbVie in Q4 2016 and has held it in 33 quarters since.
- Winning Points Advisors's AbbVie position peaked at $1.57M in Q4 2025.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Winning Points Advisors's 13F filing for Q1 2026, filed 30 Jun 2026.